GEN Exclusives

More »

GEN News Highlights

More »
Oct 3, 2006

Oncalis and ChemDiv Tackle Cancer-related Kinase Targets

  • Oncalis and ChemDiv entered into an R&D collaboration to discover candidates inhibiting receptor tyrosine kinase and other cancer-related targets. Oncalis will apply its yeast cell-based technology and develop biological assays, and ChemDiv will apply its medicinal chemistry and in vitro and in vivo biology services.

    ChemDiv provided the source for leads to the yeast-based screening platform that is now completely acquired by Oncalis, together with a high-throughput screening platform and IP rights on research projects.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?